177 related articles for article (PubMed ID: 17330785)
21. [Expression and subcellular localization of APOBEC3G in peripheral blood mononuclear cells and liver tissues of chronic HBV patients].
Chen H; Wang LW; Chu XG; Yan SN; Gong ZJ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):5-8. PubMed ID: 20128960
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
23. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
Kamada K; Igarashi T; Martin MA; Khamsri B; Hatcho K; Yamashita T; Fujita M; Uchiyama T; Adachi A
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16959-64. PubMed ID: 17065315
[TBL] [Abstract][Full Text] [Related]
24. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM; Gaddis NC; Malim MH
Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
[TBL] [Abstract][Full Text] [Related]
25. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
Ulenga NK; Sarr AD; Thakore-Meloni S; Sankalé JL; Eisen G; Kanki PJ
J Infect Dis; 2008 Aug; 198(4):486-92. PubMed ID: 18598197
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
[TBL] [Abstract][Full Text] [Related]
27. The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme.
Sharma S; Patnaik SK; Taggart RT; Baysal BE
Sci Rep; 2016 Dec; 6():39100. PubMed ID: 27974822
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.
Rose KM; Marin M; Kozak SL; Kabat D
J Biol Chem; 2004 Oct; 279(40):41744-9. PubMed ID: 15297452
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
Zhang H
Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
[TBL] [Abstract][Full Text] [Related]
30. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
[TBL] [Abstract][Full Text] [Related]
31. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
32. The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.
Ma C; Liu P; Cui S; Gao C; Tan X; Liu Z; Xu R
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144542
[TBL] [Abstract][Full Text] [Related]
33. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
Nowarski R; Britan-Rosich E; Shiloach T; Kotler M
Nat Struct Mol Biol; 2008 Oct; 15(10):1059-66. PubMed ID: 18820687
[TBL] [Abstract][Full Text] [Related]
34. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
35. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
36. Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization.
Graziano F; Aimola G; Forlani G; Turrini F; Accolla RS; Vicenzi E; Poli G
Sci Rep; 2018 Sep; 8(1):14249. PubMed ID: 30250078
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3G targets human T-cell leukemia virus type 1.
Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
[TBL] [Abstract][Full Text] [Related]
38. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs.
Tan J; Wang X; Devadas K; Zhao J; Zhang P; Hewlett I
J Cell Physiol; 2013 Dec; 228(12):2305-13. PubMed ID: 23696271
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.
Monteleone K; Di Maio P; Cacciotti G; Falasca F; Fraulo M; Falciano M; Mezzaroma I; D'Ettorre G; Turriziani O; Scagnolari C
Med Microbiol Immunol; 2014 Jun; 203(3):207-16. PubMed ID: 24553842
[TBL] [Abstract][Full Text] [Related]
40. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
Kaiser SM; Emerman M
J Virol; 2006 Jan; 80(2):875-82. PubMed ID: 16378989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
